OpenVSafe by OpenVAERS
Search V-safe

897-14740-58956

3 vaccinations 7 coded responses 28 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
461 / IN
Registered
2021-01-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-26
    Registered in v-safe
  2. 2021-01-26
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-26
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  7. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-02-02
    Survey response — day 7, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-09
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Lymphadenopathy, Neck pain — Feeling: Good · Be unable to do your normal daily activities
    Free text: Sustained civically lymphadenopathy but started improving yesterday . Neck hurt and super tired. Much better today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-16
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-18
    Dose 2 — Pfizer-BioNTech
  14. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  16. 2021-02-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-20
    Survey response — 3 months, dose 2
    MedDRA: Lymphadenopathy, Postmenopausal haemorrhage, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Post menopausal bleeding and cervical lymphadenopathy · Healthcare visit (other): Endometrial biopsy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-20
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-08-19
    Survey response — 6 months, dose 2
    MedDRA: COVID-19, Dyspnoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Covid -19 sx and now sustained sob
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-08-19
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  26. 2021-08-20
    Call successful
    Participant prefers to complete VAERS report online
  27. 2021-08-20
    Call successful
    Participant prefers to complete VAERS report online
  28. 2021-09-25
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-04
    Survey response — day 7, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Abdominal pain
    Free text: Swollen lymph nodes on side of injection
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-11
    Survey response — day 14, dose 3
    MedDRA: Injection site rash — Feeling: Good
    Free text: Mild rash at injection site . Have had for a few days
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-09
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-12-25
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-09-27
    Survey response — 12 months, dose 3
    MedDRA: Neck pain, Physiotherapy, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Continued pain in the side of my neck that I had the lymphadenopathy after my first shot · Healthcare visit (other): Physical therapy
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-09-27
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  38. 2022-09-28
  39. 2022-09-28
  40. 2022-09-28
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-26Pfizer-BioNTech
22021-02-18Pfizer-BioNTech
32021-09-25Pfizer-BioNTech No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 3 — day 7, dose 1

2021-02-02

Systemic reaction (other): Lymphadenopathy

Release 3 — day 14, dose 1

2021-02-09

Symptoms: Sustained civically lymphadenopathy but started improving yesterday . Neck hurt and super tired. Much better today

Release 8 — 3 months, dose 2

2021-05-20

Symptoms: Post menopausal bleeding and cervical lymphadenopathy
Healthcare visit (other): Endometrial biopsy

Release 9 — 6 months, dose 2

2021-08-19

Symptoms: Covid -19 sx and now sustained sob

Release 10 — day 7, dose 3

2021-10-04

Systemic reaction (other): Swollen lymph nodes on side of injection

Release 10 — day 14, dose 3

2021-10-11

Symptoms: Mild rash at injection site . Have had for a few days

Release 12 — 12 months, dose 3

2022-09-27

Symptoms: Continued pain in the side of my neck that I had the lymphadenopathy after my first shot
Healthcare visit (other): Physical therapy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOPhysiotherapy · · ✓
HCVOUnevaluable event ✓ ✓ ✓
SDCOVID-19 ✓ · ✓
SDDyspnoea ✓ · ✓
SDFatigue ✓ ✓ ✓
SDInjection site rash · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDNeck pain ✓ ✓ ✓
SDPostmenopausal haemorrhage ✓ ✓ ✓
SDPre-existing disease · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release